Lung cancer screening by spiral CT. What is the optimal target population for screening trials?

Lung Cancer

Volumn 38, Issue 3, 2002, Pages 243-252

  Van Klaveren, Rob J ^a   De Koning, Harry J ^a   Mulshine, James ^b   Hirsch, Fred R ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

Age cut off levels; Co morbidity; Lung cancer; Risk assessment; Screening; Selection criteria; Spiral CT

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; HUMAN; LUNG TUMOR; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; PRACTICE GUIDELINE; RADIOGRAPHY; RISK ASSESSMENT; RISK FACTOR; SMOKING; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; BODY WEIGHT; BREAST CANCER; BREATH HOLDING; CANCER MODEL; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; COMORBIDITY; FITNESS; HIGH RISK POPULATION; KIDNEY CARCINOMA; LIFE EXPECTANCY; LUNG CANCER; MELANOMA; PRIORITY JOURNAL; RECUMBENCY; THORAX SCINTISCANNING; THORAX SURGERY;

ADULT; AGE FACTORS; AGED; CLINICAL TRIALS; GUIDELINES; HUMANS; LUNG NEOPLASMS; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; SMOKING; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 0036889692     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00222-2     Document Type: Article

References (65)

1. Maxwell Parkin D. Global cancer statistics in the year 2000. Lancet Oncol. 2:2001;533-543.
2. Henschke C.I., McCauley D.I., Yankelevitz D.F., et al. Early lung cancer action project: overall design and findings from baseline screening. Lancet. 354:1999;99-105.
3. van Klaveren R.J., Habbema J.D.F., Pedersen J.H., Oudkerk M., Hoogsteden H.C. Lung cancer screening by low-dose spiral computed tomography. Eur. Respir. J. 18:2001;857-866.
4. Hirsch F.R., Franklin W.A., Gazdar A.F., Bunn P.A. Early detection of lung cancer: clinical perspective of recent advances in biology and radiology. Clin. Cancer Res. 7:2001;5-22.
5. Smith R.A., Glynn T.J. Epidemiology of lung cancer. Radiol. Clin. North Am. 38:2000;453-470.
6. Skuladottir H., Olsen J.H., Hirsch F.R. Incidence of lung cancer in Denmark: historical and actual status. Lung Cancer. 27:2000;107-118.
7. Jemal A., Chu K.C., Tarone R.E. Recent trends in lung cancer mortality in the United States. J. Natl. Cancer Inst. 93:2001;277-283.
8. Burns D.M. Primary prevention, smoking and smoking cessation. Implications for future trends in lung cancer prevention. Cancer. 89:2000;2506-2509.
9. Samet J.M. The epidemiology of lung cancer. Chest (Suppl). 103:1993;20S-29S.
10. Beckett W.S. Epidemiology and etiology of lung cancer. Clin. Chest Med. 14:1993;1-15.
11. Hammond E.C. Smoking in relation to the death of one million men and women. Natl. Cancer Inst. Monogr. 19:1966;127-204.
12. Doll R., Peto R. Mortality in relation to smoking: 20 years observation on male British doctors. Br. Med. J. 2:1976;1525-1536.
13. Rogot E., Murray J.L. Smoking and causes of death among US veterans: 16 years of observation. Public Health Rep. 95:1980;213-222.
14. Damber L.A., Larsson L.G. Smoking and lung cancer with special regard to type of smoking and type of cancer: a case-control study in north Sweden. Br. J. Cancer. 53:1986;673-681.
15. Cederlof R., Friberg L., Hrubec Z. The relationship of smoking and smoke: social co-variables to mortality and cancer morbidity-a 10 year follow-up in probability sample of 55 000 Swedish subjects age 18 to 69 (Part 1 and 2). 1975;Department of Environmental Hygiene, The Karolinska Institute, Stockholm, Sweden.
16. Samet J.M., Wiggins C.L., Humble C.G., Pathak D.R. Cigarette smoking and lung cancer in New Mexico. Am. Rev. Respir. Dis. 137:1988;1110-1113.
17. Weiss W., Boucot K.R., Seidman H., Carnahan W.J. Risk of lung cancer according to histologic type and cigarette dosage. J. Am. Med. Assoc. 222:1972;799-801.
18. Rylander R., Axelsson G., Andersson L., Liljequist T., Bergman B. Lung cancer, smoking and diet among Swedish men. Lung Cancer. 14:1996;s75-s83.
19. Peto R. Influence of dose and duration of smoking on lung cancer rates. Zaridge D., Peto R., Tobacco: a major international health hazard. 1986;23-33 International Agency for Research on Cancer, Lyon, France.
20. Haldorsen T., Grimsrud T.K. Cohort analysis of cigarette smoking and lung cancer incidence among Norwegian women. Int. J. Epidemiol. 28:1999;1032-1036.
21. Simonato L., Agudo A., Ahrens W., et al. Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int. J. Cancer. 91:2001;876-887.
22. Centers for Disease Control, Public health Service, US Department of Health and Human Services. The Health Benefits of Smoking Cessation. Washington DC: US Government Printing Office, 1990.
23. Tong L., Spitz M.R., Fueger J.J., Amos C.A. Lung carcinoma in former smokers. Cancer. 78:1996;1004-1010.
24. Halpern M.T., Gillespe B.W., Warner K.E. Patterns of absolute risk of lung cancer mortality in former smokers. J. Natl. Cancer Inst. 85:1993;457-464.
25. Schottenfeld D. Etiology and epidemiology of lung cancer. Pass H., Mitchell J.B., Johnson D.H., Turissi, Minna J.D., Lung cancer, principles and practice. 2000;367-388 Lippincott Williams and Wilkins, Philadelphia.
26. Wakai K., Seki N., Tamakoshi A., et al. Decrease in risk of lung cancer death in males after smoking cessation by age at quitting: findings from the JACC study. Jpn. J. Cancer Res. 92:2001;821-828.
27. Burns D.M. Tobacco smoking. Samet J.M., Epidemiology of lung cancer. 1994;15-50 Marcel Dekker, New York. Chapter 2.
28. Minami H., Yoshimura M., Matsuoka H., Toshihiko S., Tsubota N. Lung cancer treated surgically in patients <50 years of age. Chest. 120:2001;32-36.
29. Radzikowska E., Roszkowski K., Glaz P. Lung cancer in patients under 50 years old. Lung Cancer. 33:2001;203-211.
30. Morrone D., Ambrogetti D., Bravetti P., Catarzi S., Ciatto S., Rosselli del Turco M. Diagnostic errors in mammography. I. False negative results. Radiol. Med. 82:1991;212-217.
31. Swedish Cancer Society and the Swedish National Board of Health and Welfare. Breast-cancer screening with mammography in women aged 40-49 years. Int. J. Cancer. 68:1996;693-699.
32. Midthun D.E., Swensen S.J., Jett J.R. Clinical strategies for solitary pulmonary nodule. Annu. Rev. Med. 43:1992;195-208.
33. Moskowitz M. Breast cancer: age-specific growth rates and screening strategies. Radiology. 161:1986;37-41.
34. Maruyama R., Yoshino I., Yohena T., et al. Lung cancer in patients younger than 40 years of age. J. Surg. Oncol. 77:2001;208-212.
35. Janssen-Heijnen M.L.G., Schipper R.M., Razenberg P.P.A., Crommelin M.A., Coebergh J.-W.W. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer. 21:1998;105-113.
36. De Rijke J.M., Schouten L.J., Schouten H.C., Jager J.J., Koppejan A.G., van den Brandt P.A. Age-specific differences in the diagnosis and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. Ann. Oncol. 7:1996;677-685.
37. Goodwin J.S., Hunt W.C., Samet J.M. Determinants of cancer therapy in elderly patients. Cancer. 71:1993;524-529.
38. Jacobs D.R., Adachi H., Mulder I., et al. Cigarette smoking and mortality risk. Twenty-five-years follow-up of the Seven Countries Study. Arch. Int. Med. 159:1999;733-740.
39. Tabak C., Arts I.C., Smit H.A., Heederik D., Kromhout D. Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN study. Am. J. Respir. Crit. Care Med. 164:2001;61-64.
40. Connett J.E., Bjornson-Benson W.M., Daniels K. Recruitment of participants in the Lung Health Study II. Assessment of recruiting strategies: Lung Health Study Research Group. Control. Clin. Trials. 14:1993;38s-51s.
41. Zielinski J., Bednarek M. Early detection of COPD in a high-risk population using spirometric screening. Chest. 119:2001;731-736.
42. Sahn S.A., Nett L.M., Petty T.L. Ten year follow-up of a comprehensive rehabilitation program for severe COPD. Chest (Suppl). 77:1980;311-314.
43. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: developments and validation. J. Chron. Dis. 40:1987;373-383.
44. Romano P.S., Roos L.L., Jollis J.G. Adapting a clinical comorbidity index for use of a clinical comorbidity index with ICD-9-CM administrative data. J. Clin. Epidemiol. 46:1993;1085-1090.
45. Cleves M.A., Sanchez N., Draheim M. Evaluation of two competing methods for calculating Charlson's comorbidity index when analysing short-term mortality using administrative data. J. Clin. Epidemiol. 50:1997;903-908.
46. Wilson J.M.P., Jungner G. Principles and practice of screening for disease. Public Health Papers. 1968;39 WHO, Genève.
47. Marcus P.M., Bergstralh E.J., Fagerstrom R.M., et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J. Natl. Cancer Inst. 92:2000;1308-1316.
48. Kubik A., Polak J. Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer. 57:1986;2427-2437.
49. Rowell N.P., Williams C.J. Radical radiotherapy for stage I/II non-small lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax. 56:2001;628-638.
50. Guidelines on the selection of patients with lung cancer for surgery. Thorax. 56:2001;89-108.
51. ACC/AHA guidelines for peri-operative cardiovascular evaluation for non-cardiac surgery. Circulation. 93:1996;1280-1317.
52. Teplick R. Preoperative cardiac assessment of the thoracic surgical patient. Anaesthesia. 7:1997;655-696.
53. Girish M., Trayner E., Dammann O., Pinto-Plata V., Celli B. Symptom-limited stair climbing as a predictor of postoperative cardiopulmonary complications after high-risk surgery. Chest. 120:2001;1147-1151.
54. Kinasewitz G.T., Welch M.H. A simple method to assess postoperative risk. Chest. 120:2001;1057-1058.
55. Pollock M., Roa J., Benditt J., Celli B. Estimation of ventilatory reserve by stair climbing. A study in patients with chronic airflow obstruction. Chest. 104:1993;1378-1383.
56. Pate P., Tenholder M.F., Griffin J.P., Eastridge C.E., Weiman D.S. Preoperative assessment of the high-risk patient for lung resection. Ann. Thorac. Surg. 61:1996;1494-1500.
57. Kreeger K.Y. Cancer screening in older patients: making decisions about age cut-offs. J. Natl. Cancer Inst. 93:2001;1198-1199.
58. Fry W.A., Menck H.R., Winchester D.P. The National cancer data base report on lung cancer. Cancer. 77:1996;1947-1955.
59. Malmberg R., Bergman B., Branehog I., Larsson S., Olling S., Wernstedt L. Lung cancer in west Sweden 1996-1985. Acta Oncologica. 35:1996;185-192.
60. Swensen S.J., Jett J.R., Sloan J.A., et al. Screening for lung cancer with low-dose spiral computed tomography. Am. J. Respir. Crit. Care Med. 165:2002;508-513.
61. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J. Clin. 49:1999;44-46.
62. Walter S.D., Kubic A., Parkin D.M., Ressigova J., Adamec M., Khlat M. The natural history of lung cancer estimated from the results of a randomized trial of screening. Cancer Causes Control. 3:1992;115-123.
63. Fentiman I.S., Tirelli U., Monfardini S., et al. Cancer in the elderly: why so badly treated. Lancet. 28:1990;1020-1022.
64. Van Zandwijk N., Dalesio O., Pastorino U., de Vries N. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. J. Natl. Cancer Inst. 92:2000;977-986.
65. Younes R.N., Gross J.L., Deheinzelin D. Follow-up in lung cancer. How often and for what purpose. Chest. 115:1999;1494-1499.